1 |
Catalão CHR, Costa LHAD, Santos JRD, Alberici LC, Falconi LLS, Coimbra NC, Barichello T, Rocha MJA. 3-Hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase inhibitor modulates biomarkers related to Alzheimer's disease pathology in a sepsis-surviving rat model.. [DOI: 10.21203/rs.3.rs-2375120/v1] [Reference Citation Analysis]
|
2 |
Tomkins-netzer O, Niederer R, Lightman S. The Role of Statins in Diabetic Retinopathy. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.11.003] [Reference Citation Analysis]
|
3 |
Chen Y, Shi S, Dai Y. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy. Biomedicine & Pharmacotherapy 2022;156:113903. [DOI: 10.1016/j.biopha.2022.113903] [Reference Citation Analysis]
|
4 |
Tan Q, Shen X, Yang H, Xu X, Guo Y, He J, Liu Q, Du X, Wang D, Zhao L. Buffer Coefficient as a Predictor of the Prognosis of Massive Cerebral Infarction. World Neurosurgery 2022. [DOI: 10.1016/j.wneu.2022.10.023] [Reference Citation Analysis]
|
5 |
Liu X, Luo W, Huang H, Fan J. Statins on Spontaneous Intracerebral Hemorrhage: A Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/2342159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Ugovšek S, Šebeštjen M. Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall. JCM 2022;11:3625. [DOI: 10.3390/jcm11133625] [Reference Citation Analysis]
|